Christopher E.M. Griffiths
Christopher E.M. Griffiths
Professor of Dermatology, University of Manchester
Verified email at manchester.ac.uk
Title
Cited by
Cited by
Year
Pathogenesis and clinical features of psoriasis
CEM Griffiths, JNWN Barker
The Lancet 370 (9583), 263-271, 2007
18522007
Secukinumab in plaque psoriasis—results of two phase 3 trials
RG Langley, BE Elewski, M Lebwohl, K Reich, CEM Griffiths, K Papp, ...
New England Journal of Medicine 371 (4), 326-338, 2014
15232014
Global epidemiology of psoriasis: a systematic review of incidence and prevalence
R Parisi, DPM Symmons, CEM Griffiths, DM Ashcroft
Journal of Investigative Dermatology 133 (2), 377-385, 2013
15022013
Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial
K Reich, FO Nestle, K Papp, JP Ortonne, R Evans, C Guzzo, S Li, ...
The Lancet 366 (9494), 1367-1374, 2005
11552005
Psoriasis: epidemiology, clinical features, and quality of life
RGB Langley, GG Krueger, CEM Griffiths
Annals of the rheumatic diseases 64 (suppl 2), ii18-ii23, 2005
9682005
Rook's textbook of dermatology
T Burns, S Breathnach, N Cox, C Griffiths
John Wiley & Sons, 2008
9652008
Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis
CEM Griffiths, BE Strober, P van de Kerkhof, V Ho, R Fidelus-Gort, ...
New England Journal of Medicine 362 (2), 118-128, 2010
8952010
Keratinocytes as initiators of inflammation
JNWN Barker, CEM Griffiths, BJ Nickoloff, RS Mitra, VM Dixit
The Lancet 337 (8735), 211-214, 1991
8631991
A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1
A Strange, F Capon, CCA Spencer, J Knight, ME Weale, MH Allen, ...
Nature genetics 42 (11), 985, 2010
8572010
European S3-guidelines on the systemic treatment of psoriasis vulgaris
D Pathirana, AD Ormerod, P Saiag, C Smith, PI Spuls, A Nast, J Barker, ...
8092009
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
LC Tsoi, SL Spain, J Knight, E Ellinghaus, PE Stuart, F Capon, J Ding, ...
Nature genetics 44 (12), 1341-1348, 2012
7732012
A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction
KA Papp, S Tyring, M Lahfa, J Prinz, CEM Griffiths, AM Nakanishi, R Zitnik, ...
British Journal of Dermatology 152 (6), 1304-1312, 2005
7562005
Definition of treatment goals for moderate to severe psoriasis: a European consensus
U Mrowietz, K Kragballe, K Reich, P Spuls, CEM Griffiths, A Nast, J Franke, ...
Archives of dermatological research 303 (1), 1-10, 2011
7172011
Cyclosporine improves psoriasis in a double-blind study
CN Ellis, DC Gorsulowsky, TA Hamilton, JK Billings, MD Brown, ...
Jama 256 (22), 3110-3116, 1986
6301986
Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial
TN Brooklyn, MGS Dunnill, A Shetty, JJ Bowden, JDL Williams, ...
Gut 55 (4), 505-509, 2006
6202006
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
CEM Griffiths, K Reich, M Lebwohl, P van de Kerkhof, C Paul, A Menter, ...
The Lancet 386 (9993), 541-551, 2015
6172015
Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis.
BJ Nickoloff, GD Karabin, JN Barker, CE Griffiths, V Sarma, RS Mitra, ...
The American journal of pathology 138 (1), 129, 1991
5561991
Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal inflamed skin: Modulation by recombinant gamma interferon and tumor necrosis factor
CEM Griffiths, JJ Voorhees, BJ Nickoloff
Journal of the American Academy of Dermatology 20 (4), 617-629, 1989
5461989
British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009
CH Smith, AV Anstey, J Barker, AD Burden, RJG Chalmers, DA Chandler, ...
British Journal of Dermatology 161 (5), 987-1019, 2009
5262009
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded …
A Blauvelt, M de Bruin-Weller, M Gooderham, JC Cather, J Weisman, ...
The Lancet 389 (10086), 2287-2303, 2017
5132017
The system can't perform the operation now. Try again later.
Articles 1–20